Behind Our Reporting on Puberty Blockers

We scoured the scientific evidence, interviewed doctors around the world and spoke to patients and families. Here’s a closer look at what we found.

The Disease Took Zara, Then Sara. Could Ayla Be Saved?

Two sisters in one family died from a genetic disorder. Before a third child with the disease was born, doctors hatched a plan to spare her of its effects.

Study Shows New Covid Booster Improves Protection for Older People, Pfizer Says

Federal officials are hoping that the encouraging results will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.

New Covid Variants Are Circulating. Here’s What to Know.

The “nightmare variant” is not as bad as it sounds.

Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement

The last remaining defendants in New York’s once-sprawling opioid trial settled on Thursday.

Indian Drugs, Sold Worldwide, Sometimes Deadly

Deaths from contaminated cough syrups in Gambia have brought attention to loose regulations in India and a lack of testing capacity in poor importing nations.

Private Medicare Plans Misled Customers Into Signing Up, Senate Report Says

The report points to widespread misbehavior by the plans and the marketing firms they hire.

CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases

The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.

A Surge of Overseas Abortion Pills Blunted the Effects of State Abortion Bans

New data suggests that abortion has declined about 2 percent in the U.S. since the end of Roe, accounting for people who traveled across state lines or ordered pills online.